Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 850-52-2
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15DAY
Payment Terms: D/A,L/C,D/P,Western Union,T/T,MoneyGram
Supply Ability: G,KG,TON
Appearance:: |
Slightly Yellow Powder |
CAS NO:: |
850-52-2 |
Molecular Formula:: |
C21H26O2 |
Molecular Weight:: |
310.43000 |
EINECS NO:: |
212-703-1 |
MDL NO:: |
MFCD00867855 |
Appearance:: |
Slightly Yellow Powder |
CAS NO:: |
850-52-2 |
Molecular Formula:: |
C21H26O2 |
Molecular Weight:: |
310.43000 |
EINECS NO:: |
212-703-1 |
MDL NO:: |
MFCD00867855 |
Product Description:
Product Name: Altrenogest CAS NO: 850-52-2
Synonyms:
17-allylt-renbolone;
ru2267;
drc6246;
Chemical & Physical Properties:
Appearance: Slightly yellow powder
Assay :≥99.00%
Density: 1.15 g/cm3
Boiling Point: 495.6℃ at 760 mmHg
Melting Point: 120℃
Flash Point: 210.1℃
Refractive Index: 1.594
Storage Condition: 0-6℃
Safety Information:
HS Code: 2937290090
Altrenogest (INN, USAN, BAN) (brand name Regumate), also known as allylt-renbolone, is a s-teroidal progestin that is widely used in veterinary medicine to suppress estrus in animals. Altrenogest(A35957; RU2267) is a progestogen structurally related to veterinary s-teroid t-renbolone.Target: Progesterone ReceptorAltrenogest is a progestogen structurally related to veterinary s-teroid t-renbolone. Treatment of embryo-recipient mares with altrenogest appears to be beneficial in extending the degree of donor-recipient synchrony required for successful embryo transfer. Altrenogest treatment also seems to be conductive to pregnancy maintenance in recipients experiencing luteal dysfunction. The oil and gel altrenogest preparations are equally effective in modulating estrous behavior and time to estrus and ovulation. Altrenogest treatment started late in diestrus appears to result in a high incidence of ovulation during treatment and when luteolysis and ovulation occur during treatment; the subsequent luteal phase is frequently prolonged due to failure of regression of the CL.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.